Dengue vaccine already available in private clinics: know everything!

The application of the dengue vaccine will begin this week in private clinics. The National Health Surveillance Agency (Anvisa) approved the use of immunizer for people aged between 4 and 60 years in the country.

The new vaccine, called “Qdenga (TAK-003)“, will be available in private clinics from July 1, according to information from CNN. The Brazilian Association of Vaccine Clinics (ABCVAC) announced that the price of the vaccine will vary between R$ 350.00 and R$ 500.00 for consumers, depending on the state.

In relation to São Paulo, the maximum amount established for the vaccine is R$ 379.40. ABCVAC reported in a statement that clinics will take this value into account as a reference to determine the final price of the vaccine. This final price will also include services such as care, screening and analysis of the vaccination booklet, pre- and post-vaccination guidance, in addition to the support necessary to correctly inform patients about vaccination.

In clinical trials, the Qdenga vaccine demonstrated an overall efficacy of 80.2% in preventing dengue caused by any serotype. The vaccine also reduced hospitalizations by 90%. In December 2022, the European Medicines Agency (EMA) authorized the use of the vaccine in the European Union.

_{Dengue mosquito, Aedes aegypti (Photo: Reproduction/G1/Lauren Bishop)}

Dengue prevention: To prevent dengue fever, it is important not to allow standing water to accumulate anywhere, from large containers, such as water tanks and swimming pools, to small objects, such as bottle caps and potted plants. These measures help eliminate potential breeding grounds for the Aedes aegypti mosquito, responsible for transmitting the dengue virus.

Main symptoms of dengue: The main symptoms of dengue include high fever (above 38°C), body and joint aches, pain behind the eyes, malaise, lack of appetite, headache and red spots on the body . The severe form of the disease can present symptoms such as intense and continuous abdominal pain, nausea, persistent vomiting and mucous bleeding. Dengue hemorrhagic fever, the most severe form of the disease, is more common when a person contracts the virus a second time.

Featured photo: Vaccine, called “Qdenga (TAK-003)“, will be available in private clinics from July 1. Reproduction/Tânia Rêgo / Agência Brasil